Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties

Reuters07-23

Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties

Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the China Securities Regulatory Commission (CSRC) regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2553773217?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-23 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553773217","market":"fut","top_or_hot":-1,"title":"Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the <a href=\"https://laohu8.com/S/601066\">China Securities</a> Regulatory Commission (CSRC) regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-23 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the <a href=\"https://laohu8.com/S/601066\">China Securities</a> Regulatory Commission (CSRC) regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDLT6VMh:1","article_id":"2553773217","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553773217","pubTimestamp":1753270958,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the China Securities Regulatory Commission  regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1161":"生物科技","02179":"瑞科生物-B"},"translate_title":"江苏瑞生物科技有限公司在不确定性中等待监管部门批准内资股发行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02179":0.9},"content_text":"Jiangsu Recbio Technology Co. Ltd. Awaits Regulatory Approval for Domestic Share Issuance Amidst Uncertainties\n    \n\n        Jiangsu Recbio Technology Co., Ltd. has announced that it has received a reply from the China Securities Regulatory Commission (CSRC) regarding the issuance of domestic shares. The regulatory approval is part of an ongoing review process, and the issuance is contingent upon the fulfillment of certain conditions outlined in previous announcements and circulars. Jiangsu Recbio Technology is committed to keeping its shareholders and potential investors informed about the progress of this issuance in compliance with the Inside Information Provisions and Listing Rules. As of now, there is no indication that the grant or funding involves multiple organizations; it appears to be solely related to Jiangsu Recbio Technology Co., Ltd.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief on July 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2553773217","isCrawlerRequest":true}